How health charities and patient organizations can access full-text research, check evidence for patient information, and buy only the PDFs they need.
GLP-1 Research Roundup: Seven Studies Beyond Diabetes
Seven studies published from June through September 2026 examine GLP-1-based medicines beyond diabetes, including surgery, hair shedding, prescribing, heart rhythm and pediatric obesity. Explore the questions, findings and limitations, with links to the papers on DeepDyve.
Full Text for Variant Curation: Read Before You Buy the PDF
Variant curation depends on details that abstracts leave out. Learn how DeepDyve helps teams read full-text papers before buying PDFs, check journal coverage and organize supporting evidence.
Full-Text Access for Pharmacovigilance: Read First, Buy What You Need
How pharmacovigilance teams get full text on day zero, keep the evidence, and buy only the papers they must retain. A practical guide with a one-month test.
Legal Sci-Hub Alternatives in 2026: Where DeepDyve Fits
Sci-Hub ceased adding new papers around 2021, leaving no perfect substitute for accessing paywalled research. Free legal options include Unpaywall, preprint servers, ResearchGate, and email requests to authors, each with limitations. DeepDyve offers a paid alternative at $59 per month, providing access to over 35 million paywalled papers while linking to open-access content. However, it does not include works from major publishers like Elsevier. Alternatives like Anna’s Archive can be legally risky and unreliable. For those needing recent papers, combining free methods with paid subscriptions is often essential to mitigate obstacles in obtaining research.
DeepDyve vs. Zotero, Mendeley, and EndNote: One Reference Manager Gives You the Actual Paper
Zotero, Mendeley, and EndNote organize research you already have. DeepDyve gives you the actual paper: streaming access to 35M+ paywalled papers plus reference management.